PP 36
Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma
Lido
2470
Vezesque se leu este artigo
1153
Total PDF
1317
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 11 | 31 | 17 | 48 |
| 2025 10 | 47 | 22 | 69 |
| 2025 9 | 53 | 30 | 83 |
| 2025 8 | 37 | 17 | 54 |
| 2025 7 | 48 | 34 | 82 |
| 2025 6 | 43 | 19 | 62 |
| 2025 5 | 51 | 22 | 73 |
| 2025 4 | 29 | 11 | 40 |
| 2025 3 | 53 | 10 | 63 |
| 2025 2 | 35 | 16 | 51 |
| 2025 1 | 32 | 16 | 48 |
| 2024 12 | 25 | 15 | 40 |
| 2024 11 | 38 | 11 | 49 |
| 2024 10 | 22 | 19 | 41 |
| 2024 9 | 34 | 19 | 53 |
| 2024 8 | 30 | 25 | 55 |
| 2024 7 | 23 | 21 | 44 |
| 2024 6 | 22 | 18 | 40 |
| 2024 5 | 24 | 24 | 48 |
| 2024 4 | 23 | 14 | 37 |
| 2024 3 | 16 | 13 | 29 |
| 2024 2 | 24 | 22 | 46 |
| 2024 1 | 16 | 21 | 37 |
| 2023 12 | 16 | 24 | 40 |
| 2023 11 | 34 | 46 | 80 |
| 2023 10 | 17 | 22 | 39 |
| 2023 9 | 18 | 25 | 43 |
| 2023 8 | 14 | 6 | 20 |
| 2023 7 | 21 | 8 | 29 |
| 2023 6 | 17 | 18 | 35 |
| 2023 5 | 18 | 15 | 33 |
| 2023 4 | 7 | 0 | 7 |
| 2023 3 | 12 | 14 | 26 |
| 2023 2 | 12 | 11 | 23 |
| 2023 1 | 12 | 6 | 18 |
| 2022 12 | 11 | 12 | 23 |
| 2022 11 | 14 | 12 | 26 |
| 2022 10 | 16 | 17 | 33 |
| 2022 9 | 20 | 17 | 37 |
| 2022 8 | 10 | 13 | 23 |
| 2022 7 | 11 | 24 | 35 |
| 2022 6 | 8 | 13 | 21 |
| 2022 5 | 11 | 18 | 29 |
| 2022 4 | 10 | 25 | 35 |
| 2022 3 | 12 | 19 | 31 |
| 2022 2 | 13 | 19 | 32 |
| 2021 1 | 12 | 18 | 30 |
| 2021 12 | 13 | 20 | 33 |
| 2021 11 | 16 | 18 | 34 |
| 2021 10 | 19 | 31 | 50 |
| 2021 9 | 23 | 28 | 51 |
| 2021 8 | 25 | 29 | 54 |
| 2021 7 | 12 | 25 | 37 |
| 2021 6 | 11 | 20 | 31 |
| 2021 5 | 12 | 32 | 44 |
| 2021 4 | 23 | 48 | 71 |
| 2021 3 | 23 | 17 | 40 |
| 2021 2 | 10 | 12 | 22 |
| 2020 1 | 11 | 14 | 25 |
| 2020 12 | 11 | 10 | 21 |
| 2020 11 | 6 | 11 | 17 |
Mostrar tudo
